RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $77,730,340 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $44,380,166 | 32.86% |
| MV Management XI, L.L.C. | 1,971,908 | $14,730,153 | 25.77% |
| MIC Capital Management UK LLP | 8,451,758 | $63,134,635 | 12.84% |
| Yong Rong (HK) Asset Management Ltd | 1,174,200 | $8,772 | 3.85% |
| ArchPoint Investors | 1,114,626 | $8,326,256 | 3.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,711,148 | $20,252,276 | 0.70% |
| HARVARD MANAGEMENT CO INC | 882,129 | $6,590 | 0.65% |
| Diametric Capital, LP | 119,906 | $895,698 | 0.40% |
| Lingotto Investment Management LLP | 775,077 | $5,789,825 | 0.37% |
| ALLEN OPERATIONS LLC | 217,657 | $1,625,898 | 0.36% |
| Duquesne Family Office | 1,385,950 | $10,353 | 0.36% |
| HAMILTON LANE ADVISORS LLC | 96,474 | $721 | 0.32% |
| Comprehensive Financial Management LLC | 1,109,395 | $8,287,181 | 0.27% |
| Cercano Management LLC | 978,051 | $7,306,041 | 0.25% |
| Values First Advisors, Inc. | 53,426 | $399,094 | 0.24% |
| ARK Investment Management | 4,738,517 | $35,396,723 | 0.23% |
| Baillie Gifford | 25,097,630 | $187,479,296 | 0.16% |
| Bienville Capital Management, LLC | 56,876 | $424,864 | 0.14% |
| Laurion Capital Management LP | 3,178,179 | $23,740,997 | 0.13% |
External links
This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q2 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.